Browsing by Author "Lucia, Jessica Lauren"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Effect of Omega 3 Polyunsaturated Fatty Acids (PUFAs) on Markers of Inflammation in Young Horses in Training(2011-02-22) Lucia, Jessica LaurenSixteen horses (2 to 4 yr; 357 to 439 kg BW) were utilized in a randomized complete block design for a 140 d trial to determine effect of omega 3 PUFAs (n-3) supplementation on markers of inflammation in young horses in training. Horses were fed treatments consisting of a control diet (n = 8) fed at 1% BW (as fed) or a treatment diet (n = 8) of concentrate fed at 0.75% BW (as fed) and 350 g of a marine n-3 supplement formulated to provide 15 g of eicosapentaenoic acid (EPA) and 20 g of docosahexaenoic acid (DHA). Body weight and body condition scores (BCS) were obtained biweekly and concentrate adjusted accordingly. Horses were exercised 5 d/wk by students in an equine training course. Type of activity and duration was monitored, along with heart rate to quantify workload. Exercise protocol was divided into 2 phases: phase I (d 0 to110) consisted of ground work and early training under saddle, and phase II (d 111 to 140) consisted of advance maneuvers and moderate workload. Synovial fluid was obtained from right radial carpal joint by arthrocentesis every 28 d and was analyzed for white blood cell count (WBC), total protein (TP), and specific gravity (SG). Serum concentrations of carboxypeptide type II collagen (CPII) and chondroitin sulfate 846 (CS-846) were analyzed by ELISA kits. Dietary treatment did not affect synovial WBC, TP, or SG. Also, concentrations of WBC and TP also did not differ over time. SG increased over time (P < 0.001) as horses moved from phase I to phase II of the trial. Dietary treatment did not influence concentrations of CPII or CS-846. CS-846 tended to increase over time (P = 0.09) and CPII concentrations also increased (P < 0.001) in response to changes in exercise. Furthermore, all horses gained BW and BCS throughout the trial (P < 0.001), but values were not influenced by treatment. This data indicates further studies are needed to determine the efficacy of n-3 supplementation as a preventative measure against development of osteoarthritis.Item Influence of an Intra-articular Lipopolysaccharide Challenge on Markers of Inflammation and Cartilage Metabolism and the Ability of Oral Glucosamine to Mitigate these Alterations in Young Horses(2013-02-04) Lucia, Jessica LaurenThis project established an in vivo method to identify and manipulate expression of markers of osteoarthritis (OA). Specifically, strategies that predictably induce joint inflammation to evaluate dietary methods of OA prevention in young horses have yet to be accomplished. Therefore, the 3 studies described herein were conducted to determine effectiveness of an intra-articular lipopolysaccharide (LPS) challenge on markers of inflammation and cartilage metabolism in young horses and potential of dietary glucosamine hydrochloride (HCl) to mitigate these alterations. In the first study, horses were challenged with 0.25 ng or 0.50 ng of intra-articular LPS solution or lactated ringer?s solution (control). Injection of LPS increased inflammation based on synovial prostaglandin E2 (PGE2) concentrations. Carboxypeptide of type II collagen (CPII), a maker of type II collagen synthesis, also increased in a dose-dependent manner. However, clinical parameters of health were not influenced and remained within normal ranges. Carpal circumference increased in response to repeated arthrocentesis. Lameness scores increased with LPS injection when compared to controls. This model of joint inflammation (0.5 ng LPS) was used in the second study to evaluate potential chondroprotective effects of oral glucosamine HCl supplementation in yearling horses. Specifically, the oral absorption of glucosamine HCl versus saline was determined by nasogastric dosing and incorporation of dietary glucosamine HCl into plasma and synovial fluid over time. Plasma and synovial fluid concentrations of glucosamine tended to increase over the 98-d period. In the third study, yearlings were challenged with intra-articular LPS to determine the potential of glucosamine HCl to mitigate inflammation when compared to contralateral joints. Injection of LPS increased synovial PGE2 and cartilage biomarkers CPII and collagenase cleavage neopeptide (C2C), a marker of type II collagen degradation. Oral glucosamine HCl decreased PGE2 and C2C concentrations, but increased levels of CPII. Results of these 3 studies provide a clearer understanding of joint inflammation and cartilage turnover in young horses and demonstrated a potential role of oral glucosamine to mitigate these effects and possibly prevent OA in horses.